-
公开(公告)号:WO2022214678A2
公开(公告)日:2022-10-13
申请号:PCT/EP2022/059492
申请日:2022-04-08
申请人: VALNEVA SE
发明人: LUNDBERG, Urban , MEINKE, Andreas , PERUGI, Fabien
IPC分类号: A61K39/12 , C12N2760/18334
摘要: The present invention relates to a vaccine composition for preventing and/or treating a respiratory system infection such as a human metapneumovirus infection of the respiratory system. This vaccine composition comprises one, two or more modified human metapneumovirus (hMPV) F proteins or variants thereof provided in a pre-fusion -fusion conformation form.
-
公开(公告)号:WO2020234300A1
公开(公告)日:2020-11-26
申请号:PCT/EP2020/063973
申请日:2020-05-19
申请人: VALNEVA SE
IPC分类号: A61K39/12 , A61K39/155 , A61P31/14 , C07K14/115 , C12N15/00
摘要: The present invention relates to modified metapneumovirus (hMPV) F proteins, stabilized in the pre-fusion conformation. It also relates to immunogenic compositions (vaccines) comprising these proteins for preventing and/or treating human subjects against respiratory tract infections.
-
公开(公告)号:WO2020012037A1
公开(公告)日:2020-01-16
申请号:PCT/EP2019/069030
申请日:2019-07-15
申请人: VALNEVA SE
IPC分类号: C07K14/005 , C12N7/00 , C12N15/86
摘要: The present invention relates to methods of rescue and/or propagation of paramyxovirus species, particularly wherein both rescue and propagation are carried out in the same cell type; i.e., without the use of helper cells for viral rescue. The paramyxoviruses produced by the disclosed methods may encompass wild-type viruses, chimeric viruses, recombinant viruses or engineered viral products such as virus like particles (VLP). Viruses and/or viral products produced in the method according to the current invention are suitable for medical or veterinary use in such applications as treating or preventing infectious diseases, particularly avian paramyxovirus and human respiratory virus infections, and cancer treatment.
-
公开(公告)号:WO2022214685A2
公开(公告)日:2022-10-13
申请号:PCT/EP2022/059502
申请日:2022-04-08
申请人: VALNEVA SE
发明人: LUNDBERG, Urban , MEINKE, Andreas , PERUGI, Fabien
IPC分类号: A61K39/12 , A61K2039/55505 , A61K2039/55561 , A61K2039/55566 , A61K2039/55572 , A61P31/14 , C12N2760/18334
摘要: The present invention relates to a vaccine composition for preventing and/or treating a respiratory system infection such as a human metapneumovirus infection of the respiratory system. This vaccine composition comprises two or more modified human metapneumovirus (hMPV) F proteins or variants thereof provided in a pre-fusion and/or post-fusion conformation form.
-
公开(公告)号:WO2019092002A1
公开(公告)日:2019-05-16
申请号:PCT/EP2018/080424
申请日:2018-11-07
申请人: VALNEVA SE
发明人: PITARD, Bruno , HANSON, Melissa , LAHMAR, Mehdi , PERUGI, Fabien , SCHWAMBORN, Klaus , GUEHENNEUX, Fabienne
IPC分类号: A61K39/155 , A61K39/39 , C07K14/005
CPC分类号: A61K39/155 , A61K39/39 , C07K14/005 , C12N2760/18322 , C12N2760/18334
摘要: Described herein are constructs and pharmaceutical compositions for the treatment or prevention of viral infections.
-
-
-
-